» Articles » PMID: 31001551

Alpha-Thalassemia in North Morocco: Prevalence and Molecular Spectrum

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2019 Apr 20
PMID 31001551
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Unlike the other hemoglobinopathies, few researches have been published concerning -thalassemia in Morocco. The epidemiological features and the mutation spectrum of this disease are still unknown. This regional newborn screening is the first to study -thalassemia in the north of Morocco. During the period from January 2015 to December 2016, 1658 newborns umbilical blood samples were investigated. Suspected newborns were screened for -globin defects using Gap-PCR and Multiplex Ligation-dependent Probe Amplification technique. The prevalence of -thalassemia, its mutation spectrum, and its allelic frequencies were described for the first time in Morocco. Six different -globin genetic disorders were detected in 16 neonates. This screening valued the prevalence of -thalassemia in the studied population at 0.96% and showed the wide mutation spectrum and the heterogeneous geographical distribution of the disease. A high rate of carriers was observed in Laouamra, a rural commune in Larache province. Heterogeneity of -globin alleles in Morocco explains the high variability of -thalassemia severity. This diversity reflects the anthropological history of the country. These results would contribute to the prevention of thalassemia in Morocco directing the design of a nationwide screening strategy and awareness campaign.

Citing Articles

Sociodemographic Factors and Consanguinity in Intellectual Disability: A Pilot Study.

Benmakhlouf Y, Laghmich A, Ben Makhlouf K, Barakat A, Ghailani Nourouti N, Bennani Mechita M Innov Clin Neurosci. 2025; 21(10):9-14.

PMID: 39790896 PMC: 11709441.


Newborn Screening for Six Primary Conditions in a Clinical Setting in Morocco.

El Janahi S, Filali M, Boudar Z, Akhattab A, Jaoudi R, Al Idrissi N Int J Neonatal Screen. 2024; 10(4).

PMID: 39728400 PMC: 11677151. DOI: 10.3390/ijns10040080.


Mapping maternal and infant health in Morocco: A global scoping review of themes, gaps, and the "unseen" in the published health research literature, 2000-2022.

Amster E, Jessani G, Gupta G, Hlyva O, Rae C PLOS Glob Public Health. 2024; 4(7):e0003488.

PMID: 39024351 PMC: 11257357. DOI: 10.1371/journal.pgph.0003488.


Bridging the gaps in newborn screening programmes: Challenges and opportunities to detect haemoglobinopathies in Africa.

Twum S, Fosu K, Felder R, Sarpong K Afr J Lab Med. 2023; 12(1):2225.

PMID: 38116518 PMC: 10729498. DOI: 10.4102/ajlm.v12i1.2225.


Genetic Analysis of Alpha-Thalassemia Mutations in Thi-Gar Province, Iraq.

Odah Al-Musawi A, Jumaah Alhussna A, Hussein Jalood H Arch Razi Inst. 2023; 77(3):976-980.

PMID: 36618297 PMC: 9759236. DOI: 10.22092/ARI.2022.357209.1997.


References
1.
van der Dijs F, Volmer M, Smit J, van Veen R, Muskiet F . Predictive value of cord blood hematological indices and hemoglobin Barts for the detection of heterozygous alpha-thalassemia-2 in an African-Caribbean population. Clin Chem. 1999; 45(9):1495-500. View

2.
Kyriacou K, Kyrri A, Kalogirou E, Vasiliades P, Angastiniotis M, Ioannou P . Hb Bart's levels in cord blood and alpha-thalassemia mutations in Cyprus. Hemoglobin. 2000; 24(3):171-80. DOI: 10.3109/03630260008997525. View

3.
Weatherall D . Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet. 2001; 2(4):245-55. DOI: 10.1038/35066048. View

4.
Luk C, Ling S, Chik K, Yuen H, Li C, Shing M . Morbidity and mortality patterns of thalassaemia major patients in Hong Kong: retrospective study. Hong Kong Med J. 2002; 8(4):255-60. View

5.
Pembrey M, Weatherall D, Clegg J, BUNCH C, PERRINE R . Haemoglobin Bart's in Saudi Arabia. Br J Haematol. 1975; 29(2):221-34. DOI: 10.1111/j.1365-2141.1975.tb01816.x. View